Editas Medicine (EDIT) Total Current Liabilities (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Total Current Liabilities data on file, last reported at $46.2 million in Q4 2025.

• Quarterly Total Current Liabilities fell 40.12% year-over-year to $46.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $46.2 million (down 40.12% YoY) and the FY2025 annual result came in at $46.2 million, down 40.12% from the prior year.
• Total Current Liabilities declined to $46.2 million in Q4 2025 per EDIT's latest filing, from $61.8 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $77.2 million in Q4 2024 and bottomed at $36.4 million in Q2 2022.
• The 5-year median for Total Current Liabilities is $60.9 million (2022), against an average of $58.7 million.
• The widest annual swing landed in 2022, when Total Current Liabilities tumbled 44.83%; it then soared 56.58% in 2023.
• Tracing EDIT's Total Current Liabilities over 5 years: stood at $46.9 million in 2021, then grew by 28.21% to $60.1 million in 2022, then rose by 5.17% to $63.2 million in 2023, then gained by 22.16% to $77.2 million in 2024, then tumbled by 40.12% to $46.2 million in 2025.
• Per Business Quant, the three latest EDIT Total Current Liabilities figures stand at $46.2 million (Q4 2025), $61.8 million (Q3 2025), and $65.9 million (Q2 2025).

Peer Comparison